Neural mechanisms of antidepressant efficacy of the dopamine receptor agonist pramipexole in treatment of bipolar depression

International Journal of Neuropsychopharmacology

Volumn 14, Issue 4, 2011, Pages 545-551

  Mah, Linda ^a,b   Zarate, Carlos A ^b   Nugent, Allison C ^b   Singh, Jaskaran B ^b   Manji, Husseini K ^b   Drevets, Wayne C ^b  

^a Kunin Lunenfeld Applied Research Unit and Department of Food and Nutrition Services and Baycrest Centre for Geriatric Care   (Canada)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Bipolar disorder; glucose metabolism; major depression; orbitofrontal cortex; positron emission tomography (PET)

Indexed keywords

FLUORODEOXYGLUCOSE F 18; LITHIUM; PLACEBO; PRAMIPEXOLE; VALPROATE SEMISODIUM;

ADULT; ARTICLE; BIPOLAR DEPRESSION; BRAIN METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; FEMALE; HUMAN; MALE; ORBITAL CORTEX; PARIETAL CORTEX; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; ANTIDEPRESSIVE AGENTS; ANTIMANIC AGENTS; BENZOTHIAZOLES; BIPOLAR DISORDER; BRAIN; DOPAMINE AGONISTS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LIMBIC SYSTEM; MALE; PLACEBOS; PREFRONTAL CORTEX; RADIOPHARMACEUTICALS;

EID: 79960353833     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145710001203     Document Type: Article

References (26)

1. Aiken CB (2007). Pramipexole in psychiatry : a systematic review of the literature. Journal of Clinical Psychiatry 68, 1230-1236. (Pubitemid 47395626)
2. Black KJ, Hershey T, Koller JM, Videen TO, et al. (2002). A possible substrate for dopamine-related changes in mood and behavior: prefrontal and limbic effects of a D3-preferring dopamine agonist. Proceedings of the National Academy of Sciences USA 99, 17113-17118. (Pubitemid 36034107)
3. Brody AL, Saxena S, Mandelkern MA, Fairbanks LA, et al. (2001). Brain metabolic changes associated with symptom factor improvement in major depressive disorder. Biological Psychiatry 50, 171-178. (Pubitemid 32763094)
4. Cannon DM, Ichise M, Fromm SJ, Nugent AC, et al. (2006). Serotonin transporter binding in bipolar disorder assessed using [11C]DASB and positron emission tomography. Biological Psychiatry 60, 207-217. (Pubitemid 44093448)
5. Carson RE, Daube-Witherspoon ME, Green MV (1988). A method for postinjection PET transmission measurements with a rotating source. Journal of Nuclear Medicine 29, 1558-1567.
6. Cohen J (1988). Statistical Power Analysis for the Behavioral Sciences, 2nd edn, Hillsdale, NJ : Erlbaum.
7. Drevets WC (1999). Prefrontal cortical-amygdalar metabolism in major depression. Annals of the New York Academy of Sciences 877, 614-637. (Pubitemid 29351882)
8. Drevets WC (2007). Orbitofrontal cortex function and structure in depression. Annals of the New York Academy of Sciences 1121, 499-527.
9. Drevets WC, Bogers W, Raichle ME (2002a). Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism. European Neuropsychopharmacology 12, 527-544. (Pubitemid 35408704)
10. Drevets WC, Price JL, Bardgett ME, Reich T, et al. (2002b). Glucose metabolism in the amygdala in depression: relationship to diagnostic subtype and plasma cortisol levels. Pharmacology Biochemistry and Behavior 71, 431-447. (Pubitemid 34126368)
11. Drevets WC, Videen TO, Price JL, Preskorn SH, et al. (1992). A functional anatomical study of unipolar depression. Journal of Neuroscience 12, 3628-3641.
12. Fu CH, Williams SC, Cleare AJ, Brammer MJ, et al. (2004). Attenuation of the neural response to sad faces in major depression by antidepressant treatment: a prospective, event-related functional magnetic resonance imaging study. Archives of General Psychiatry 61, 877-889. (Pubitemid 39181077)
13. Hasler G, Fromm S, Carlson PJ, Luckenbaugh DA, et al. (2008). Neural response to catecholamine depletion in unmedicated subjects with major depressive disorder in remission and healthy subjects. Archives of General Psychiatry 65, 521-531. (Pubitemid 351645048)
14. Kennedy SH, Evans KR, Kruger S, Mayberg HS, et al. (2001). Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression. American Journal of Psychiatry 158, 899-905. (Pubitemid 32547619)
15. Lai T, Payne ME, Byrum CE, Steffens DC, et al. (2000). Reduction of orbital frontal cortex volume in geriatric depression. Biological Psychiatry 48, 971-975.
16. Lozano AM, Mayberg HS, Giacobbe P, Hamani C, et al. (2008). Subcallosal cingulate gyrus deep brain stimulation for treatment-resistant depression. Biological Psychiatry 64, 461-467.
17. Mah L, Zarate Jr. CA, Singh J, Duan YF, et al. (2007). Regional cerebral glucose metabolic abnormalities in bipolar II depression. Biological Psychiatry 61, 765-775. (Pubitemid 46330241)
18. Mayberg HS, Brannan SK, Tekell JL, Silva JA, et al. (2000). Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. Biological Psychiatry 48, 830-843.
19. Mayberg HS, Liotti M, Brannan SK, McGinnis S, et al. (1999). Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. American Journal of Psychiatry 156, 675-682. (Pubitemid 29220063)
20. Montgomery SA, Asberg M (1979). A new depression scale designed to be sensitive to change. British Journal of Psychiatry 134, 382-389. (Pubitemid 9136500)
21. Moore DF, Altarescu G, Barker WC, Patronas NJ, et al. (2003). White matter lesions in Fabry disease occur in prior selectively hypometabolic and hyperperfused brain regions. Brain Research Bulletin 62, 231-240. (Pubitemid 38091711)
22. Neumeister A, Nugent AC, Waldeck T, Geraci M, et al. (2004). Neural and behavioral responses to tryptophan depletion in unmedicated patients with remitted major depressive disorder and controls. Archives of General Psychiatry 61, 765-773. (Pubitemid 39031116)
23. Rosenthal R (1991). Meta-Analytic Procedures for Social Research, revised edn. Newbury Park, CA: Sage Publications.
24. Swerdlow NR, Amalric M, Koob GF (1987). Nucleus accumbens opiate-dopamine interactions and locomotor activation in the rat : evidence for a pre-synaptic locus. Pharmacology Biochemistry and Behavior 26, 765-769.
25. Talairach J, Tournoux P (1988). Co-planar Stereotaxic Atlas of the Human Brain. New York: Thieme Publishing Group.
26. Zarate Jr. CA, Payne JL, Singh J, Quiroz JA, et al. (2004). Pramipexole for bipolar II depression: a placebo-controlled proof of concept study. Biological Psychiatry 56, 54-60. (Pubitemid 38813406)